Presentation is loading. Please wait.

Presentation is loading. Please wait.

Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs Diversity of methods utilized to model neurological diseases using.

Published byFrancine McCarthy Modified over 5 years ago

Similar presentations

Presentation on theme: "Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs Diversity of methods utilized to model neurological diseases using."— Presentation transcript:

1 Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs
Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs Pie charts illustrating the percentage distribution of disease groups and specific diseases.Venn diagram showing unique and shared experimental techniques among the examined articles.Minimal information about iPSC experiments (MiPSCE). Percentage of studies with or without the information for each category is depicted by color. Complete descriptions of the categories can be found in Materials and Methods. SMA, spinal muscular atrophy; ALS, amyotrophic lateral sclerosis; FTD, frontotemporal dementia. Ethan W Hollingsworth et al. EMBO Mol Med. 2017;emmm © as stated in the article, figure or figure legend

Download ppt "Diversity of methods utilized to model neurological diseases using patient‐derived iPSCs Diversity of methods utilized to model neurological diseases using."

Similar presentations

47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.

47-year-old with progressive upper limb weakness Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
Noninvasive Examination of Amyotrophic Lateral Sclerosis Using Surface Electromyography Ping Zhou, PhD.

Noninvasive Examination of Amyotrophic Lateral Sclerosis Using Surface Electromyography Ping Zhou, PhD.
H. influenzae genes differentially regulated during growth in complex media and during lung infection in the presence of corticosteroids AVenn diagram.

H. influenzae genes differentially regulated during growth in complex media and during lung infection in the presence of corticosteroids AVenn diagram.
Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.
by Edward J. Goetzl, Adam Boxer, Janice B. Schwartz, Erin L

by Edward J. Goetzl, Adam Boxer, Janice B. Schwartz, Erin L
Expression analyses of KLK7 mRNA in the brains of AD patients

Expression analyses of KLK7 mRNA in the brains of AD patients
The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth A22Rv1.

The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth A22Rv1.
Spatial and temporal expression patterning of dysregulated genes from neurons in vivo Spatial and temporal expression patterning of dysregulated genes.

Spatial and temporal expression patterning of dysregulated genes from neurons in vivo Spatial and temporal expression patterning of dysregulated genes.
PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.

PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.
Chia-Wei Lin, MS, Stephanie J. Kalb, PhD, Wei-Shi Yeh, PhD 

Chia-Wei Lin, MS, Stephanie J. Kalb, PhD, Wei-Shi Yeh, PhD 
Figure 2 Flow chart of patients who met the inclusion/exclusion criteria for the study Flow chart of patients who met the inclusion/exclusion criteria.

Figure 2 Flow chart of patients who met the inclusion/exclusion criteria for the study Flow chart of patients who met the inclusion/exclusion criteria.
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis

AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.

CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.
TR suppresses the assembly of NLRP3 inflammasome

TR suppresses the assembly of NLRP3 inflammasome
Preceding knockdown of FoxO3 reduces inhibitory effect of UCN‐01 on human lung fibroblast proliferation and myofibroblast transdifferentiation in response.

Preceding knockdown of FoxO3 reduces inhibitory effect of UCN‐01 on human lung fibroblast proliferation and myofibroblast transdifferentiation in response.
Phenogenetic networks of genes linked to Alzheimer's and Parkinson's disease reveal concordant phenotypes Phenogenetic networks of genes linked to Alzheimer's.

Phenogenetic networks of genes linked to Alzheimer's and Parkinson's disease reveal concordant phenotypes Phenogenetic networks of genes linked to Alzheimer's.
Figure 3 Genetic pleiotropy in ALS

Figure 3 Genetic pleiotropy in ALS
Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders Clinical testing of calcineurin inhibitors cyclosporine.

Clinical testing of calcineurin inhibitors cyclosporine A and tacrolimus in autoimmune disorders Clinical testing of calcineurin inhibitors cyclosporine.
Increased IFNγ producing CD4+ T cells in the spleen drives the enhanced splenic IFNγ on 6 dpi during concurrent co‐infection Increased IFNγ producing CD4+

Increased IFNγ producing CD4+ T cells in the spleen drives the enhanced splenic IFNγ on 6 dpi during concurrent co‐infection Increased IFNγ producing CD4+
No neurodegenerative phenotype observed in single Aph1a and Aph1bc cKO Cre+ mice No neurodegenerative phenotype observed in single Aph1a and Aph1bc cKO.

No neurodegenerative phenotype observed in single Aph1a and Aph1bc cKO Cre+ mice No neurodegenerative phenotype observed in single Aph1a and Aph1bc cKO.

Similar presentations

Ads by Google